To mark World Hand Hygiene Day, the World Health Organization (WHO) today called for countries to reduce inequalities in the availability of good hand hygiene and other infection prevention and control (IPC) measures.
Melinta Therapeutics of Morristown, New Jersey, announced yesterday that the US Food and Drug Administration (FDA) has approved Kimyrsa (oritavancin) for treatment of adult patients with acute bacterial skin and skin-structure infections (ABSSSIs) caused by susceptible gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
"Hospitals are becoming overwhelmed with more patients than can be managed with typical care standards."
An Italian study in the Journal of Antimicrobial Chemotherapy yesterday found that 21.9% of hospitalized COVID-19 patients acquired bacterial or fungal superinfections—infection by a secondary pathogen—that complicated the course of their recovery.
A new report from the Centers for Disease Control and Prevention (CDC) shows some encouraging declines in healthcare-associated infections (HAIs) across four US healthcare settings, including one linked to antibiotic use.
The Centers for Disease Control and Prevention (CDC) has issued new recommendations for the prevention and control of Staphylococcus aureus in neonatal intensive care unit (NICU) patients.
An international team of surgeons this week released a set of recommendations for preventing surgical-site infections (SSIs) that aim to improve patient outcomes, reduce unnecessary antibiotic exposure, and curb antibiotic resistance in low- and middle-income countries (LMICs).
After some fluctuations, the World Health Organization's (WHO's) online Ebola dashboard shows a case count of 3,391 today, with a single newly confirmed case since yesterday. One new death was also recorded, bringing the toll to 2,234 in an outbreak that has now lasted 17 months in the eastern region of the Democratic Republic of the Congo (DRC).
San Diego-based biopharmaceutical company Qpex Biopharma today announced it will receive a second round of funding from the Biomedical Advanced Research and Development Authority (BARDA) to develop a portfolio of antibiotics targeting antibiotic-resistant gram-negative bacteria.
After 3 days with no new cases, the Democratic Republic of the Congo (DRC) today reported 4 more Ebola cases, raising the outbreak total to 3,296 illnesses, according to the World Health Organization (WHO) online Ebola dashboard.
Health officials are still investigating 422 suspected cases. Two more people died from their infections, bringing the fatality count to 2,195.
